"According to the roadmap plan that we submitted to the Ministry of Health, although it has not yet been finally approved, we will likely receive permission at the end of August so that we can begin treating people in September," Gintsburg told the news agency.
The Gamaleya Research Institute of Epidemiology and Microbiology had previously developed Sputnik V, world's first registered Covid-19 vaccine. In 2022, the center applied mRNA technology, the basis for other Covid vaccines, to develop a new type of cancer drug.
In an interview with RT last month, the Gamaleya chief explained that the new drug is a therapeutic vaccine designed to be administered to those already diagnosed with cancer. It causes the patient's immune system to start destroying malignant cells. The shot enables Cytotoxic lymphocytes, or white blood cells, that appear in the body of a vaccinated person to recognize foreign proteins (antigens) on the surface of tumor cells. Cytotoxic lymphocytes then find foreign, metastasizing cells and destroy them throughout the body...<<<Read More>>>...